Central China New Life (HKSE:09983) EBIT: HK$266 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:09983 Central China New Life Ltd HKSE:09983
68 GF Score
Price HK$0.33
GF Value HK$1.28
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Central China New Life EBIT?

Central China New Life HKSE:09983 +1.56% 68 EBIT is HK$266 Mil as of Dec. 2025. GuruFocus rates HKSE:09983 with a GF Score™ of 68/100 and a GF Value™ of HK$1.28 (Possible Value Trap). The stock has 6 warning signs investors should review.

Central China New Life's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was HK$97 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$266 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Central China New Life's annualized ROC % for the quarter that ended in Dec. 2025 was 9.46%. Central China New Life's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 21.15%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Central China New Life's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 304.65%.


Central China New Life  (HKSE:09983) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Central China New Life's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=352.044 * ( 1 - 36.57% )/( (2137.297 + 2581.473)/ 2 )
=223.3015092/2359.385
=9.46 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4866.189 - 1815.527 - ( 913.365 - max(0, 2517.076 - 4094.365+913.365))
=2137.297

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=4784.906 - 1744.404 - ( 459.029 - max(0, 2481.789 - 3926.248+459.029))
=2581.473

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Central China New Life's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=193.474/( ( (68.789 + max(667.157, 0)) + (105.046 + max(988.406, 0)) )/ 2 )
=193.474/( ( 735.946 + 1093.452 )/ 2 )
=193.474/914.699
=21.15 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3165.989 + 6.919 + 2.2960000000003) - (1815.527 + 0 + 692.52)
=667.157

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3445.708 + 7.947 + 9.491) - (1744.404 + 0 + 730.336)
=988.406

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Central China New Life's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=265.647/87.197
=304.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Central China New Life EBIT Related Terms


Central China New Life EBIT Historical Data

* Premium members only.

The historical data trend for Central China New Life's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central China New Life EBIT Chart

Central China New Life Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only 1,015.70 859.34 -754.68 388.42 267.45

Central China New Life Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -363.23 197.13 192.92 168.91 96.74

HKSE:09983 vs CBRE, BEKE, JLL: EBIT Comparison

For the Real Estate Services subindustry, Central China New Life's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Central China New Life EV-to-EBIT vs Real Estate Industry

For the Real Estate industry and Real Estate sector, Central China New Life's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Central China New Life's EV-to-EBIT falls into.


HKSE:09983
68GF Score
Central China New Life Ltd HKSE:09983
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Central China New Life EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$266 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of HK$266 Mil mean?
Central China New Life (HKSE:09983) has a EBIT of HK$266 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Central China New Life.
Is Central China New Life's EBIT too high?
Central China New Life's current EBIT is HK$266 Mil. Overall, Central China New Life has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Central China New Life's EBIT compare to CBRE and BEKE?
Central China New Life's EBIT of HK$266 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Real Estate company?
A good EBIT depends on the Real Estate industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Central China New Life. Central China New Life's current EBIT is HK$266 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Central China New Life stock overvalued right now?
Based on GuruFocus' analysis, Central China New Life (HKSE:09983) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.28, compared to a current price of HK$0.33 — trading 74.6% below its estimated fair value. The current EBIT is HK$266 Mil. Central China New Life's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Central China New Life (HKSE:09983), the current EBIT is HK$266 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Central China New Life (HKSE:09983) Overvalued in 2026?

Based on GuruFocus' analysis, Central China New Life stock appears to be undervalued. The current stock price of HK$0.33 is trading 74.6% below its estimated GF Value™ of HK$1.28. GuruFocus considers Central China New Life to be Possible Value Trap.

Key valuation signals for HKSE:09983:

  • EBIT: HK$266 Mil
  • GF Value™: HK$1.28 vs. price of HK$0.33 (74.6% below fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the HKSE:09983 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Central China New Life Business Description

Address No. 19 Dirun Road, Room 411, 4th Floor, Building 2, Jianye Office Building, Zhengdong New District, Henan Province, Zhengzhou, CHN
Central China New Life Ltd is a property management company in central China with a geographical focus in Henan province. The revenue of the Group was generated from three main business lines: property management services; community value-added services; and value-added services to non-property owners. The company generates the majority of its revenue from property management services. The Group mainly operates its businesses in the PRC and earns substantially all of the revenue from customers in the PRC region.
68GF Score

Get the complete analysis for HKSE:09983

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.33
Price
HK$1.28
GF Value